Cessation of anticoagulation therapy following endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis.

CONCLUSIONS: In selected patients with acute IFDVT and patent venous stent, particularly in younger and otherwise healthy patients with May-Thurner syndrome, it appears to be safe to discontinue AT 3-12 months after endovascular treatment.
CLINICAL TRIAL REGISTRATION: The study is registered on the National Institutes of Health website (ClinicalTrials.gov; identifier NCT02433054).
PMID: 30667348 [PubMed - as supplied by publisher]

Source: VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases - January 22, 2019 Category: Surgery Authors: Sebastian T, Engelberger RP, Spirk D, Hakki LO, Baumann FA, Spescha RS, Kucher N Tags: Vasa Source Type: research